Cargando…
Potential Serum Biomarkers in Prenatal Diagnosis of Placenta Accreta Spectrum
Placenta accreta spectrum (PAS) refers to the abnormal invasion of trophoblastic tissues. Because of its increasing morbidity and possibility of catastrophic outcomes, PAS requires an antenatal diagnosis and making full preparations in advance to realize safe delivery. Current clinical screening mod...
Autores principales: | Zhang, Tianyue, Wang, Shaowei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196238/ https://www.ncbi.nlm.nih.gov/pubmed/35712096 http://dx.doi.org/10.3389/fmed.2022.860186 |
Ejemplares similares
-
Ultrasound scoring system for prenatal diagnosis of placenta accreta spectrum
por: Zhang, Junling, et al.
Publicado: (2023) -
Ultrasound as a Sole Modality for Prenatal Diagnosis of Placenta Accreta Spectrum: Potentialities and Pitfalls
por: Gulati, Anshika, et al.
Publicado: (2021) -
The prenatal diagnostic indicators of placenta accreta spectrum disorders
por: Wu, Xiafei, et al.
Publicado: (2023) -
Effect of placenta location detected by ultrasound on the severity of placenta accreta spectrum in patients with placenta previa and placenta accreta spectrum
por: Liu, Hong, et al.
Publicado: (2023) -
Placenta Accreta Spectrum Outcomes Using Tourniquet and Forceps for Vascular Control
por: Huang, Jingrui, et al.
Publicado: (2021)